Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;5(2):140-3.
doi: 10.4103/0973-6247.83239.

Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units

Janak Kishore  1 , Manisha Srivastava, Nabajyoti Choudhury
Affiliations

Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units

Janak Kishore et al. Asian J Transfus Sci. 2011 Jul.

Abstract

Background: Human parvovirus B19 (B19) virus is a newly recognized agent for transfusion transmitted diseases. Beta-thalassemia major patients receive a hypertransfusion regimen, hence, are prone to acquire B19 infection; moreover, B19 escapes viral inactivation methods and donor units are not tested for B19, but there are just a couple of studies globally and none from the Asian continent. Hence, a study was designed to find the frequency of B19 infection and its transmission in multitransfused thalassemia patients.

Materials and methods: Ninety multitransfused beta-thalassemia major (thalassemia) patients, 32 controls (age, sex matched) without any history of transfusion were enrolled. Besides the donor units were tested in B19 un-infected patients. B19 specific IgG and IgM antibodies in the sera were analyzed by ELISA (in-house), using B19 VPI and VP2 recombinant and purified antigens; additionally HBsAg and anti-HIV and anti-HCV antibodies were tested for coexisting infections.

Results: Seventy-three (81%) thalassemia patients tested positive for anti-B19 IgG antibodies as compared to seven (21%) in the controls group (P < 0.01), while anti-B19 IgM antibodies were detected in 37 (41.1%) compared to two (6.2%) in the controls (P < 0.01). Mean age of the thalassemia patient was eight years (range 2 - 18 years) and B19 infection was highest in the six-to-ten year range. Seropositivity increased with the number of transfusions. Two of the four HBsAg positive and five of the seven anti-HCV IgM antibody-positive patients also had anti-B19 IgM. After a six-month follow-up, four (25%) of the 16 seronegative patients seroconverted and anti-B19 IgM antibodies were detected in their donor units.

Conclusions: Most of multitransfused thalassemics were B19 seropositive or had anti-B19 IgM; in the remaining uninfected group, B19 got transmitted through infected / IgM-positive donor units.

Keywords: B19; blood transfusion; parvovirus; seroconversion; thalassemia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kishore J, Kapoor A. Erythrovirus B19 infections in humans. Indian J Med Res. 2000;112:149–64. - PubMed
    1. Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol. 2010;20:231–44. - PubMed
    1. Lefrère JJ, Maniez-Montreuil M, Morel P, Defer C, Laperche S. Safety of blood products and B19 parvovirus. Transfus Clin Biol. 2006;13:235–41. - PubMed
    1. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007;44:32–41. - PMC - PubMed
    1. Ragni MV, Sherman KE, Jordan JA. Viral pathogens. Haemophilia. 2010;16(Suppl 5):40–6. - PubMed